CSIMarket
 
Mannkind Corporation  (NASDAQ: MNKD)
 

Mannkind's Suppliers Performance

MNKD's Supply Chain




 
MNKD Costs vs Sales of Suppliers Growth Mannkind's cost of sales deteriorated by -9.72 % year on year, sequentially cost of sales grew by 44.61 % in Q2.

More on MNKD Suppliers



Mannkind's cost of sales deteriorated by -9.72 % year on year, sequentially cost of sales grew by 44.61 % in Q2.

More on MNKD Suppliers




Mannkind's Comment on Supply Chain


Furoscix manufacturing depends on raw materials that are limited and sourced from one or a few suppliers. V-Go is produced by a contract manufacturing organization (CMO) in Southern China using MannKind-owned equipment, with additional CMOs in China responsible for testing, sterilization, inspection, and packaging. Components for V-Go are made to specifications, with some parts obtained from single-source vendors managed through a global supply chain. Alternative suppliers are considered available if needed. The nintedanib dry powder formulation is manufactured in Connecticut, with nintedanib sourced from generic drug substance suppliers. Suppliers and contract manufacturers are experienced multinational organizations subject to inspections and Good Manufacturing Practice (GMP) audits. Quality and manufacturing personnel qualify new vendors and regularly audit operations. Facilities of CMOs and critical suppliers are inspected by the FDA and other regulatory agencies.

Mannkind's Comment on Supply Chain


Furoscix manufacturing depends on raw materials that are limited and sourced from one or a few suppliers. V-Go is produced by a contract manufacturing organization (CMO) in Southern China using MannKind-owned equipment, with additional CMOs in China responsible for testing, sterilization, inspection, and packaging. Components for V-Go are made to specifications, with some parts obtained from single-source vendors managed through a global supply chain. Alternative suppliers are considered available if needed. The nintedanib dry powder formulation is manufactured in Connecticut, with nintedanib sourced from generic drug substance suppliers. Suppliers and contract manufacturers are experienced multinational organizations subject to inspections and Good Manufacturing Practice (GMP) audits. Quality and manufacturing personnel qualify new vendors and regularly audit operations. Facilities of CMOs and critical suppliers are inspected by the FDA and other regulatory agencies.







MNKD's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Mannkind Corporation 1,032.70 393.63 -43.61 592
SUBTOTAL 0.00 0.00 0.00 -


Sources: Mannkind Corporation's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Mannkind Corporation’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.